Bronchodilator Market to Total US$ 67.8 Billion by 2034 on the Back of Rising Geriatric Population and Growing Prevalence of Respiratory Disease | Future Market Insights Inc.
November 22, 2023 12:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The global bronchodilator market value is predicted to increase from US$ 38.2 billion in 2024 to US$ 67.8 billion by 2034. Over the forecast period,...
Bronchodilators Global Market Report 2023: Sector to Reach $45 Billion by 2030 at a 4.7% CAGR
June 15, 2023 04:38 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bronchodilators Market to Reach...
Global Bronchodilators Market to 2030: Increasing Prevalence of Lung Diseases Drives Growth
June 06, 2023 06:28 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators Market Size, Share & Trends Analysis Report By Disease (Asthma, COPD), By Route Of Administration (Inhalable, Oral), By Drug Class...
Global Bronchodilators Market to Reach $27 Billion by 2028: Increasing Air Pollution Across the World Drives Growth
March 17, 2023 10:13 ET
|
Research and Markets
Dublin, March 17, 2023 (GLOBE NEWSWIRE) -- The "Global Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic...
Nasal delivery devices Market Forecast to 2027: Global COVID-19 Impact and Analysis by Drug Type, Delivery Technologies, End User
November 24, 2020 02:48 ET
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Delivery Technologies; End User, and Geography"...
Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc.
January 07, 2020 12:30 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. (“FCL”) is pleased to announce that its President and CEO, Dr. Luigi Franciosi, has been retained as a...
Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting
May 17, 2013 08:00 ET
|
Pearl Therapeutics
REDWOOD CITY, CALIF, May 17, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the Company would
be presenting four posters at the upcoming annual meeting of the
American Thoracic...